cost plus drugs tirzepatide Mark Cuban's Getting Into the GLP-1 Space, Finally Mark Cuban's Cost Plus partners

Make sure youre getting enough to preserve muscle mass

Compounded medications have not undergone the same rigorous testing as FDA-approved medications and may vary in their content

Evercore analyst Umer Raffat said he thinks Pfizer is likely buying some time to see how a different obesity pill its studying performs

Another [way Medicare might cover weight-loss drugs] is for some kind of demonstration project from the Biden administration to see whether drugs prescribed for weight-loss have other beneficial effects, such as lowering cholesterol or helping with heart disease, and whether that in turn produces long-term savings, notes Neuman

One such promising medication is Tirzepatide, a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist

Official J Am Coll Gastroenterol | ACG